Prevalência e possíveis fatores associados a não adesão à terapêutica da colite ulcerativa em remissão

Loading...
Thumbnail Image

Journal Title

Journal ISSN

Volume Title

Publisher

Universidade Federal de Juiz de Fora (UFJF)

DOI

Abstract

Ulcerative colitis (UC) is a chronic inflammatory disease whose manifestations can drastically affect the quality of life of patients. Therefore, treatment adherence is important in order to keep it in remission. Individual factors may interfere with the continuity of the patient's treatment in remission. To verify the prevalence of non-adherence and the influence of the sociodemographic, clinical and pharmacotherapeutic characteristics associated with non-adherence to the treatment of UC in remission. A cross-sectional study was conducted with adults presenting UC in remission followed at the Clinical Gastroenterology outpatient clinic of the Clinical Gastroenterology Ambulatory of Universitary Hospital, in Juiz de Fora, Minas Gerais, Brazil, between August 2017 and January 2018. Factors of risk for non-adherence to treatment were investigated by applying a questionnaire on sociodemographic, clinical and pharmacotherapeutic characteristics of the patient. The Morisky Therapeutic Adhesion Scale (MMAS-8), Beck Depression Inventory (BDI) and Subscale of Anxiety of seven items of the Hopitalar Anxiety and Depression Scale were also applied. A total of 90 patients were included, with a mean age of 50.41±12.94 years. The prevalence of non-adherence to therapy was 77.8% and we did not identified among 21 variables analyzed anyone associated with non-adherence prevalence. High proportions of patients with UC in remission presented non-adherents to therapy; however, we did not found characteristics among sociodemographic, clinical and pharmacotherapeutic data that would be able to explain this behavior, alerting the need for greater attention of health professionals to this important aspect of treatment.

Description

Citation

Endorsement

Review

Supplemented By

Referenced By

Rights and licensing

Acesso Embargado